Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,118
Total Claims
$1.0M
Drug Cost
186
Beneficiaries
$5,393
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,372 Medical Oncology providers
+111%
Opioid rate vs peers
12.3% vs 5.9% avg
-56%
Cost per patient vs peers
$5,393 vs $12K avg
Opioid Prescribing
12.3%
Opioid Rate
138
Opioid Claims
$3,856
Opioid Cost
15.2%
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 964 claims · $42K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Abemaciclib | 11 | $173K |
| Rivaroxaban | 26 | $25K |
| Abiraterone Acetate | 23 | $25K |
| Apixaban | 32 | $19K |
| Hydrocodone/Acetaminophen | 66 | $2,158 |
| Anastrozole | 105 | $2,073 |
| Letrozole | 39 | $1,134 |
| Tamoxifen Citrate | 28 | $882 |
| Omeprazole | 47 | $863 |
| Gabapentin | 70 | $760 |
| Escitalopram Oxalate | 41 | $613 |
| Morphine Sulfate | 15 | $517 |
| Diphenoxylate Hcl/Atropine | 31 | $467 |
| Prednisone | 64 | $457 |
| Acyclovir | 33 | $453 |
Prescribing Profile
Patient Profile
72
Avg Age
62%
Female
2.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About